HealthEquity Inc. (HQY)
NASDAQ: HQY · Services-Business Services, NEC · Draper, UT
Our rating: Positive
Positive reaffirmed at $96.37, moderate conviction, August 28, 2026.
Breaks if: The Positive call breaks down if revenue growth decelerates to below 5% on a trailing twelve-month basis in any reported quarter over the next four quarters, or if FCF margin falls below 28% for two consecutive reported periods — either would unwind the core growth-plus-cash-conversion argument that justifies the current multiple. On the price side, a drawdown of 20% from today within twelve months, absent a broad market dislocation, would signal that near-term fundamental weakness is surfacing in reported results ahead of what the annual figures currently show.
Key figures
| Market value | $7.8B |
|---|---|
| Revenue, last 12 months | $1.4B |
| Net income, last 12 months | $236M |
| Free cash flow, last 12 months | $488M |
| Price to earnings | 33.1× |
| Free cash flow yield | 6.2% |
| Dividend yield | 0.0% |
| Operating margin | 25.8% |
| Return on equity | 11.4% |
| Beta to the S&P 500 | 0.86 |
| Volatility, annualized | 37.8% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| July 31, 2026 | $351M | 7.6% | $0.78 | $135M |
| April 30, 2026 | $355M | 7.2% | $0.82 | $97M |
| January 31, 2026 | $335M | 7.3% | $0.58 | $118M |
| October 31, 2025 | $322M | 7.2% | $0.59 | $138M |
| July 31, 2025 | $326M | 8.6% | $0.68 | $135M |
| April 30, 2025 | $331M | 15.0% | $0.61 | $65M |
| January 31, 2025 | $312M | 18.8% | $0.30 | $75M |
| October 31, 2024 | $300M | 20.5% | $0.06 | $90M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $0.35B: Claude 72%, Gemini 85%, Mistral 65%
- Diluted earnings per share are at least $0.59: Claude 62%, Gemini 95%, Mistral 80%
- Free cash flow for the quarter is at least $0.14B: Claude 55%, Gemini 75%, Mistral 55%
- Backlog at the end of the quarter is at least $0.00B: Claude 97%, Gemini 99%, Mistral 99%
7 ledger entries and 61 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.